Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
A highly cytotoxic macrocyclic lactone polyether has been isolated from a Spongia species and named spongistatin 1. With L1210 murine leukemia cells an IC50 value for cell proliferation of 20 pM was obtained, and an increase in the mitotic index concordant with the decrease in cell number was observed. Kangaroo rat kidney PtK1 cells were examined by indirect immunofluorescence with a spongistatin 1 concentration that caused 50% reduction in cellular protein (0.3 nM) and with a 10-fold higher concentration. These cells displayed mitotic and nuclear aberrations at both concentrations, and intracellular microtubules were reduced in number at the lower concentration and disappeared at the higher. Similar changes in PtK1 cells were observed after treatment with equivalent toxic concentrations of the antimitotic agents colchicine, vinblastine, halichondrin B, and dolastatin 10. Spongistatin 1 inhibited the glutamate-induced polymerization of purified tubulin (IC50 value of 3.6 microM versus 2.1 microM for dolastatin 10 and vinblastine and 5.2 microM for halichondrin B). Spongistatin 1 had no effect on the binding of colchicine to tubulin, but it was a potent inhibitor of the binding of vinblastine and GTP to tubulin. In initial experiments with 5 microM tubulin and 5 microM vinblastine, spongistatin 1 and dolastatin 10 both had IC50 values of 2 microM, whereas halichondrin B had an IC50 value of 5 microM. Spongistatin 1 thus represents a new member of the group of complex natural products that inhibit mitosis by binding in the Vinca alkaloid domain of tubulin.
Bai
R
R
Laboratory of Molecular Pharmacology, National Cancer Institute, Institutes of Health, Bethesda, Maryland 20892.
Cichacz
Z A
ZA
Herald
C L
CL
Pettit
G R
GR
Hamel
E
E
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000633:toxicity; D002455:Cell Division / Q000187:drug effects; D047630:Depsipeptides; D004988:Ethers, Cyclic / Q000494:pharmacology* / Q000633:toxicity; D006160:Guanosine Triphosphate / Q000378:metabolism; D007783:Lactones / Q000494:pharmacology* / Q000633:toxicity; D007939:Leukemia L1210 / Q000188:drug therapy / Q000473:pathology; D018942:Macrolides; D008387:Marine Toxins / Q000494:pharmacology* / Q000633:toxicity; D051379:Mice; D008870:Microtubules / Q000187:drug effects* / Q000378:metabolism; D008938:Mitosis / Q000187:drug effects*; D009842:Oligopeptides / Q000494:pharmacology; D011161:Porifera; D014404:Tubulin / Q000378:metabolism*; D014747:Vinblastine / Q000378:metabolism*; D000095702:Polyether Toxins; D000095662:Polyether Polyketides
D000970:Antineoplastic Agents; D047630:Depsipeptides; D004988:Ethers, Cyclic; D006160:Guanosine Triphosphate; D007783:Lactones; D018942:Macrolides; D008387:Marine Toxins; D009842:Oligopeptides; D014404:Tubulin; D014747:Vinblastine; C083856:spongistatin 1; D000095702:Polyether Toxins; C070519:halichondrin B; D000095662:Polyether Polyketides; C064570:dolastatin 10